View All Key Stats
VSTM Key Stats
| Income Statement | |
| Revenue (TTM) | -- |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -1.81 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -75.85M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -- |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 374.22M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | -- |
| PE Ratio (TTM) | -- |
| Price to Book Value | 9.707 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | -22.56M |
| Return on Equity (TTM) | Upgrade |
View All VSTM News
VSTM News
-
WireHeadlineTime (ET)
-
Business Wire06/16 06:30
-
MT Newswires06/15 16:53
-
MT Newswires06/15 16:33
-
MT Newswires06/15 12:47
-
SA Breaking News06/15 12:36
-
SA Breaking News06/15 11:00
-
MT Newswires06/15 09:22
-
SA Breaking News06/15 09:19
-
Globe Newswire06/15 08:25
-
MT Newswires06/14 17:53
View All Events
VSTM Events
| Date | Type | Description |
|---|---|---|
| 08/08/2018 | Earnings | Verastem Inc Second Quarter Earnings Results in 2018 |
| 05/16/2018 | Misc | Verastem Inc Annual General Meeting in 2017 |
| 05/03/2018 | Earnings | Verastem Inc First Quarter Earnings Results in 2018 |
| 03/13/2018 | Earnings | Verastem Inc Fourth Quarter Earnings Results in 2017 |
| 11/07/2017 | Earnings | Verastem Inc Third Quarter Earnings Results in 2017 |
| 08/08/2017 | Earnings | Verastem Inc Second Quarter Earnings Results in 2017 |
VSTM Fundamentals
Income Statement View Statement
VSTM Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
VSTM One Page Reports
- One Page Report Download
VSTM Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 6.53 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.verastem.com
- Investor Relations URL: http://phx.corporate-ir.net/phoenix.zhtml?c=250749&p=irol-irhome
- HQ State/Province: Massachusetts
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Value
- Next Earnings Release: Aug. 08, 2018
- Last Earnings Release: May. 03, 2018
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Verastem Inc is a biopharmaceutical company engaged in discovering and developing drugs to improve outcomes for patients with cancer. Its product candidates include duvelisib and defactinib.
VSTM Excel Add-In Codes
- Name: =YCI("VSTM","name")
- Description: =YCI("VSTM","description")
- Sector: =YCI("VSTM","sector")
- Industry: =YCI("VSTM","industry")
- Est. Current Fiscal Year End: =YCI("VSTM","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other VSTM Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- VSTM Tweets Stocktwits
Advertisement
